Elevated levels of plasma inactive stromal cell derived factor-1a predict long-term adverse outcomes in diabetic patients with coronary artery disease

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Metabolic syndrome and heart disease (2) Percutaneous Coronary Intervention (PCI) and Surgery ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by